[1]
Muhammad W. Saif, MD et al. 2025. Safety and Efficacy of Biweekly Gemcitabine in Combination with Capecitabine in Elderly and Frail Patients with Resected Pancreatic Cancer. Pancreas. 6, 1 (Sep. 2025), 7–12.